Approaches to hepatitis C treatment and cure using NS5A inhibitors

Recent progress in the understanding of hepatitis C virus (HCV) biology and the availability of in vitro models to study its replication have facilitated the development of direct-acting antiviral agents (DAAs) that target specific steps in the viral replication cycle. Currently, there are three maj...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohler, James J, Nettles, James H, Amblard, Franck, Hurwitz, Selwyn J, Bassit, Leda, Stanton, Richard A, Ehteshami, Maryam, Schinazi, Raymond F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949698/
https://www.ncbi.nlm.nih.gov/pubmed/24623983
http://dx.doi.org/10.2147/IDR.S36247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949698/
https://www.ncbi.nlm.nih.gov/pubmed/24623983
http://dx.doi.org/10.2147/IDR.S36247

Ejemplares similares